Product
COVID-19 Booster Vaccine
1 clinical trial
6 indications
Indication
COVID-19 RecurrentIndication
lung cancerIndication
VaccinationIndication
AntibodyIndication
ChemotherapyIndication
Immune Checkpoint InhibitorClinical trial
Efficacy of COVID-19 Booster-Dose Vaccine for Re-infection Precaution and Dynamics of Specific Serum Antibodies in the Management of Lung Cancer Patients With Systemic Anti-cancer TreatmentStatus: Recruiting, Estimated PCD: 2026-12-08